
THBD基因的功能与作用机制解析 - 八方基因
2024年12月28日 · THBD基因编码的蛋白叫做血栓调节蛋白(thrombomodulin),这种蛋白在血管内皮细胞表面大量表达。 它的主要功能是调节血液凝固过程,防止血栓的过度形成。
心舒宝片通过调节 THBD/ARRB1/FGF1/STIM1 信号对射血分数降低 …
中医药治疗心力衰竭(hf)的早中期在缓解和预防方面具有独特的优势。 本研究的目的是评估心舒宝(XSB)在诱发小鼠心肌梗死(MI)后心衰不同阶段的体内治疗效果,并使用基于质谱的蛋白质组学来识别潜在的治疗靶点根据 XSB 治疗后的分子变化,针对 HF 的不 ...
NM_000361.3(THBD):c.-151G>T AND Thrombomodulin-related …
Tang et al. (2013) demonstrated that the -151G-T variant in the 5-prime UTR of the THBD gene significantly reduced gene expression and caused a predisposition to venous thrombosis (THPH12; 614486). In a case-control study, heterozygotes had a 2.80-fold (95% confidence interval = 1.88-4.29) increased risk of venous thrombosis.
Cardioprotective efficacy of Xin-shu-bao tablet in heart failure with ...
2023年9月1日 · The purpose of this study was to assess the in vivo therapeutic efficacy of Xin-shu-bao (XSB) at different stages of HF following induction of a myocardial infarction (MI) in mice and use mass spectrometry-based proteomics to identify potential therapeutic targets for different stages of HF based on the molecular changes following XSB treatment.
THBD Gene - GeneCards | TRBM Protein | TRBM Antibody
2024年12月25日 · THBD (Thrombomodulin) is a Protein Coding gene. Diseases associated with THBD include Thrombophilia Due To Thrombomodulin Defect and Hemolytic Uremic Syndrome, Atypical 6. Among its related pathways are Diseases …
Antagonizing the irreversible thrombomodulin-initiated …
2023年5月11日 · Here, we identify thrombomodulin (THBD) signaling as a key molecular determinant of the senescent cell fate. Although normally restricted to endothelial cells, THBD is...
中国中医科学院:心舒宝片通过调节THBD/ARRB1/FGF1/STIM1信号 …
2023年7月7日 · 一项最新的研究发现,心血宝片(Xin-shu-bao tablet,简称XSB)在HF患者中具有良好的心脏保护效果。 研究使用小鼠模型,在心肌梗死(MI)后诱导不同阶段的HF,并通过质谱分析法确定XSB治疗后的潜在治疗靶点。 研究结果显示,XSB在HF早期阶段(HF with reduced ejection fraction,简称HFrEF)具有较高的心脏保护效果,但在HF后期阶段效果较弱或无效。 超声心动图测量结果显示,XSB降低了HF患者的射血分数和收缩分数。 XSB治疗改善了HF前后 …
Cardioprotective efficacy of Xin-shu-bao tablet in heart ... - PubMed
XSB had high cardioprotective efficacy in the pre-HF with reduced ejection fraction (HFrEF) stages, but had a weak or no effect in the post-HFrEF stages. This was supported by echocardiographic measurements showing that XSB decreased ejection fraction and fractional shortening in HF.
血栓调节素(THBD)基因 | MCE - MCE-生物活性分子大师
由这种无内含子基因编码的蛋白质是一种内皮特异性 I 型膜受体,可结合凝血酶。 这种结合导致蛋白 C 的激活,从而降解凝血因子 Va 和 VIIIa 并减少凝血酶的产生量。 该基因的突变是血栓栓塞性疾病的一个原因,也称为遗传性血栓形成倾向。 [RefSeq 提供,2008 年 7 月] The protein encoded by this intronless gene is an endothelial-specific type I …
J Thromb Haemost:血栓调节蛋白 (THBD) 基因变异与 ... - MedSci
2022年1月5日 · 尽管几项研究已经在静脉血栓栓塞(vte)患者中发现了血栓调节蛋白基因(thbd)变异,但thbd在vte患者中的作用仍有待阐明。 近日,血栓和凝血疾病权威杂志Journal of Thrombosis and Haemostasis上发表了一篇研究文章,该研究旨在明确大型中老年人群中罕见和常见THBD变异 …